"Drugs Show Promise In Fighting Breast, Lung, And Prostate Cancers"
Several drugs are scoring big wins against common cancers, setting new standards for how to treat many prostate, breast and lung tumors. There's even a "uni-drug" that may fight many forms of the disease. What's especially striking: The drugs are beneficial in some cases for more than a year, much longer than the few months many new drugs provide. Stephen Malamud, MD, associate professor of medical oncology at the Icahn School of Medicine at Mount Sinai talks about a drug called Xeloda, which can extend the lives of some women whose breast cancer is not wiped out by standard treatment.
- Stephen Malamud, MD, Associate Professor, Medicine, Hematology, Medical Oncology, Icahn School of Medicine at Mount Sinai
Study Reveals New Insights Into Immune System Role in Lung Cancer Risk
Feb 22, 2024 View All Press Releases
Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer
Jan 26, 2024 View All Press ReleasesMount Sinai’s Staten Island Cancer Center Moves to New Site
Nov 09, 2023 View All Press Releases
Scientists Create Most Powerful, Accurate Tool Yet to Research Deadliest Blood Cancer
Apr 18, 2023 View All Press Releases